Immunomedics, Inc.
(NASDAQ : IMMU)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.70%342.801.2%$619.65m
GILDGilead Sciences, Inc.
-0.62%72.470.9%$507.56m
CELGCelgene Corporation
-0.44%89.971.2%$494.21m
AMGNAmgen Inc.
-0.06%197.311.2%$485.07m
ILMNIllumina, Inc.
0.31%326.893.5%$374.85m
REGNRegeneron Pharmaceuticals, Inc.
-0.41%372.732.6%$314.49m
VRTXVertex Pharmaceuticals Incorporated
-0.90%174.501.9%$207.20m
ALXNAlexion Pharmaceuticals, Inc.
0.26%116.302.0%$187.07m
AAgilent Technologies, Inc.
0.11%64.731.5%$159.45m
SRPTSarepta Therapeutics, Inc.
-0.31%129.8516.6%$142.02m
NKTRNektar Therapeutics
0.45%60.305.6%$126.86m
BLUEBluebird Bio, Inc.
-0.60%157.0514.6%$120.84m
EXASExact Sciences Corporation
-0.76%48.4725.3%$117.92m
BMRNBioMarin Pharmaceutical Inc.
-2.05%98.944.4%$116.31m
INCYIncyte Corporation
-0.26%68.622.5%$111.44m

Company Profile

Immunomedics, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. The company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. It markets and sells its products in the U.S. and throughout Europe. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.